Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Materials Today. Bio
|
June 23, 2025
Norcantharidin/Cu<sup>2+</sup> dual-depleting GSH nanocatalyst with pH-responsive for CT/CDT synergistic cancer therapy
Xiaohuan Guo, Bingbing Cai, Qi Fang, et al.
Heliyon
|
November 30, 2023
Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study
Rongqiang Liu, Shinan Wu, Hao Yuan Yu, et al.
Journal of Colloid and Interface Science
|
June 3, 2026
A pH/glutathione-dual-responsive drug-loaded heterostructure nanozyme for synergistic chemotherapy/chemodynamic therapy against melanoma
Yuzhu Zhou, Yanfei Liu, Yufeng Feng, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
September 29, 2025
Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies
Yutao Chen, Desheng Chen, Zhixing Liang, et al.
Infectious Agents and Cancer
|
January 17, 2023
Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
Jianming Yang, Yewu Chen, Haobin Sun, et al.
Chinese Medical Journal
|
March 11, 2025
Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion
Haoyuan Yu, Mengchen Shi, Xuejiao Li, et al.
Oncology Reports
|
February 6, 2020
Ginsenoside CK induces apoptosis and suppresses proliferation and invasion of human osteosarcoma cells through the PI3K/mTOR/p70S6K1 pathway
Kang Chen, Jianbao Jiao, Jinwei Xue, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2025
FXR-mediated antigen-specific CD8<sup>+</sup> T cell enhances antitumor immunity in intrahepatic cholangiocarcinoma
Shanshan Liu, Zhixing Liang, Lisi Zhu, et al.
Nature Communications
|
November 24, 2023
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8<sup>+</sup> exhausted-like T cells
Siqi Li, Kun Li, Kang Wang, et al.
Biomaterials
|
December 19, 2025
Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma
Yongwei Hu, Kaiming He, Mingshen Zhang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Materials Today. Bio
|
June 23, 2025
Norcantharidin/Cu<sup>2+</sup> dual-depleting GSH nanocatalyst with pH-responsive for CT/CDT synergistic cancer therapy
Xiaohuan Guo, Bingbing Cai, Qi Fang, et al.
Heliyon
|
November 30, 2023
Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study
Rongqiang Liu, Shinan Wu, Hao Yuan Yu, et al.
Journal of Colloid and Interface Science
|
June 3, 2026
A pH/glutathione-dual-responsive drug-loaded heterostructure nanozyme for synergistic chemotherapy/chemodynamic therapy against melanoma
Yuzhu Zhou, Yanfei Liu, Yufeng Feng, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
September 29, 2025
Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies
Yutao Chen, Desheng Chen, Zhixing Liang, et al.
Infectious Agents and Cancer
|
January 17, 2023
Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
Jianming Yang, Yewu Chen, Haobin Sun, et al.
Chinese Medical Journal
|
March 11, 2025
Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion
Haoyuan Yu, Mengchen Shi, Xuejiao Li, et al.
Oncology Reports
|
February 6, 2020
Ginsenoside CK induces apoptosis and suppresses proliferation and invasion of human osteosarcoma cells through the PI3K/mTOR/p70S6K1 pathway
Kang Chen, Jianbao Jiao, Jinwei Xue, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2025
FXR-mediated antigen-specific CD8<sup>+</sup> T cell enhances antitumor immunity in intrahepatic cholangiocarcinoma
Shanshan Liu, Zhixing Liang, Lisi Zhu, et al.
Nature Communications
|
November 24, 2023
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8<sup>+</sup> exhausted-like T cells
Siqi Li, Kun Li, Kang Wang, et al.
Biomaterials
|
December 19, 2025
Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma
Yongwei Hu, Kaiming He, Mingshen Zhang, et al.
Page
of 3